 <h1>Bedaquiline Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of bedaquiline include:</b> headache and nausea. <b>Other side effects include:</b> hepatic insufficiency, increased liver enzymes, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, increased serum transaminases, and anorexia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bedaquiline: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>An increased risk of death was seen bedaquiline treatment group compared to the placebo treatment group in one placebo-controlled trial in adults. Only use bedaquiline in patients 12 years or age and older when an effective treatment regimen cannot otherwise be provided. QT prolongation can occur with bedaquiline. Use of other QT prolonging drugs may cause additive QT prolongation. Monitor ECG. Discontinue bedaquiline if significant ventricular arrhythmia or if a QTc interval of greater than 500 milliseconds develops.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bedaquiline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking bedaquiline:</p><p>
<i>More common</i>
</p><ul>
<li>Chest pain</li>
<li>coughing or spitting up blood</li>
<li>dark-colored urine</li>
<li>decreased appetite</li>
<li>fever</li>
<li>general feeling of tiredness or weakness</li>
<li>headache</li>
<li>itching or skin rash</li>
<li>light-colored stools</li>
<li>loss of appetite</li>
<li>nausea and vomiting</li>
<li>stomach pain or tenderness</li>
<li>swelling of the feet or lower legs</li>
<li>unusual tiredness or weakness</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dizziness or fainting</li>
<li>fast or irregular heartbeat</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bedaquiline may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Difficulty with moving</li>
<li>muscle pain or stiffness</li>
<li>pain in the joints</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bedaquiline: oral tablet</i></p><h3>Musculoskeletal</h3><p>Arthralgia was reported in 40% of pediatric patients (12 to 18 years).  The side effect occurred in up to 33% of adults.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Arthralgia (up to 40%)</p>
<p><b>Common</b> (1% to 10%): Myalgia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 38%), vomiting (up to 20.6%), abdominal pain (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Blood amylase increased, diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 28%), dizziness (up to 12.7%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hemoptysis (up to 18%), chest pain (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Electrocardiogram QT prolonged/QT prolongation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Increased mortality risk (up to 11.4%)</p>
<p><b>Common</b> (1% to 10%): Death</p>
<p><b>Frequency not reported</b>: Drug interactions<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Aminotransferases at least 3 times upper limit of normal (up to 10.8%)</p>
<p><b>Common</b> (1% to 10%): Increased aminotransferases/increased transferases</p>
<p><b>Frequency not reported</b>: ALT increased, AST increased, hepatotoxicity, liver enzyme increased, liver function abnormal<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Sirturo (bedaquiline)." Janssen Pharmaceuticals, Titusville, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about bedaquiline</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: diarylquinolines</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bedaquiline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Sirturo</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Tuberculosis, Resistant</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bedaquiline: oral tablet</i></p><h3>Musculoskeletal</h3><p>Arthralgia was reported in 40% of pediatric patients (12 to 18 years).  The side effect occurred in up to 33% of adults.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Arthralgia (up to 40%)</p><p><b>Common</b> (1% to 10%): Myalgia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 38%), vomiting (up to 20.6%), abdominal pain (up to 13%)</p><p><b>Common</b> (1% to 10%): Blood amylase increased, diarrhea<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 28%), dizziness (up to 12.7%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Hemoptysis (up to 18%), chest pain (up to 11%)</p><p><b>Common</b> (1% to 10%): Electrocardiogram QT prolonged/QT prolongation<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Increased mortality risk (up to 11.4%)</p><p><b>Common</b> (1% to 10%): Death</p><p><b>Frequency not reported</b>: Drug interactions<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Aminotransferases at least 3 times upper limit of normal (up to 10.8%)</p><p><b>Common</b> (1% to 10%): Increased aminotransferases/increased transferases</p><p><b>Frequency not reported</b>: ALT increased, AST increased, hepatotoxicity, liver enzyme increased, liver function abnormal<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Rash<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Anorexia<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Sirturo (bedaquiline)." Janssen Pharmaceuticals, Titusville, NJ. </p><h2>More about bedaquiline</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>Drug class: diarylquinolines</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bedaquiline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Tuberculosis, Resistant</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>